Impact of a boost dose of 16 Gy on the local control and cosmesis in patients with early breast cancer: The EORTC boost versus no boost trial

Li Liu, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 23 de octubre del 2000

Translation for this article does not exist